SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.86-0.9%10:37 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheryl Galt who wrote (26637)11/20/1998 11:56:00 AM
From: jayhawk969  Read Replies (1) of 32384
 
Cheryl,

Good digging for the manufacturing information. I had seen references to commercial production but had not found the detail in the 10-Q. My concern stemmed from:
1 the FDA statement that manufacturing was one of the concerns
2 the messiness of diptheria toxin and e-coli in the production.
3 Using someone else like Lilly for the fill process
4 lack of significant commercial production by Marathon for any product(to the best o my knowledge)

My concerns are more intuitive than hard fact. Go Ontak and Panretin.

J.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News